Úsek pro vědu a výzkum

Impaktované publikace

[21]

Šálek, C.; Vydra, J.; Cerovská, E.; Šestáková, Š.; Ransdorfová, Š.; Válková, V.; Cetkovský, P.; Remešová, H.

WT1 expression in peripheral blood at diagnosis and during the course of early consolidation treatment correlates with survival in patients with intermediate and poor-risk acute myeloid leukemia

[rok vydání 2020, impact factor 3.231 ]

[22]

Valkova, V.; Vydra, J.; Markova, M.; Cerovska, E.; Vrana, M.; Marinov, I.; Cechova, H.; Cetkovsky, P.; Vitek, A.; Salek, C.

WT1 gene expression in peripheral blood before and after allogeneic stem cell transplantation is a clinically relevant prognostic marker in AML: a single-center 14-year experience

[rok vydání 2020, impact factor 3.231 ]

[23]

Salaj, P.; Penka, M.; Smejkal, P.; Geierova, V.; Ovesna, P.; Brabec, P.; Cetkovsky, P.; Kubes, R.; Mesterton, J.; Lindgren, P.

Economic analysis of recombinant activated factor VII versus plasma-derived activated prothrombin complex concentrate in mild to moderate bleeds: haemophilia registry data from the Czech Republic

[rok vydání 2012, impact factor 3.133 ]

[24]

Kuželová, K.; Brodská, B.; Fuchs, O.; Dobrovolná, M.; Soukup, P.; Cetkovský, P.

Altered HLA class I profile associated with type A/D nucleophosmin mutation points to possible anti-nucleophosmin immune response in acute myeloid leukemia

[rok vydání 2015, impact factor 3.057 ]

[25]

Marinov, I.; Kohoutová, M.; Tkáčová, V.; Pešek, A.; Čermák, J.; Cetkovský, P.

Performance characteristics of consensus approaches for small and minor paroxysmal nocturnal hemoglobinuria clone determination by flow cytometry

[rok vydání 2013, impact factor 2.955 ]

[26]

Hájková, H.; Marková, J.; Haškovec, C.; Šárová, I.; Fuchs, O.; Kostečka, A.; Cetkovský, P.; Michalová, K.; Schwarz, J.

Decreased DNA methylation in acute myeloid leukemia patients with DNMT3A mutations and prognostic implications of DNA methylation

[rok vydání 2012, impact factor 2.764 ]

[27]

Pavlík, T.; Janoušová, E.; Pospíšil, Z.; Mužík, J.; Žáčková, D.; Ráčil, Z.; Klamová, H.; Cetkovský, P.; Trněný, M.; Mayer, J.; Dušek, L.

Estimation of current cumulative incidence of leukaemia-free patients and current leukaemia-free survival in chronic myeloid leukaemia in the era of modern pharmacotherapy

[rok vydání 2011, impact factor 2.668 ]

[28]

Šálek, C.; Folber, F.; Froňková, E.; Procházka, B.; Marinov, I.; Cetkovský, P.; Mayer, J.; Doubek, M.

Early MRD response as a prognostic factor in adult patients with acute lymphoblastic leukemia

[rok vydání 2015, impact factor 2.653 ]

[29]

Pohlreich, D.; Vitek, A.; Maalouf, J.; Cetkovsky, P.

Decreased risk of acute gastrointestinal toxicity when substituting methotrexate with mycophenolate mofetil in the prevention of graft-versus-host disease in stem cell transplantation following myeloablative conditioning regimens

[rok vydání 2007, impact factor 2.621]

[30]

Racil, Z.; Toskova, M.; Kocmanova, I.; Buresova, L.; Kouba, M.; Drgona, L.; Masarova, L.; Guman, T.; Tothova, E.; Gabzdilova, J.; Forsterova, K.; Haber, J.; Ziakova, B.; Bojtarova, E.; Rolencova, M.; Timilsina, S.; Cetkovsky, P.; Mayer, J.

Micafungin as empirical antifungal therapy in hematological patients: a retrospective, multicenter study in the Czech and Slovak Republics.

[rok vydání 2013, impact factor 2.605 ]

[31]

Zackova, D.; Klamova, H.; Muzik, J.; Cmunt, E.; Racil, Z.; Machova Polakova, K.; Dvorakova, D.; Jurcek, T.; Razga, F.; Cetkovsky, P.; Dusek, L.; Mayer, J.

Efficacy and tolerance of dasatinib after imatinib failure or intolerance for chronic myeloid leukemia patients treated in three different hospitals compare well with results achievable in formal clinical trials

[rok vydání 2013, impact factor 2.605 ]

[32]

Racil, Z.; Razga, F.; Machova Polakova, K.; Buresova, K.; Polivkova, V.; Dvorakova, D.; Zackova, D.; Klamova, H.; Cetkovsky, P.; Mayer, J.

Assessment of adenosine triphosphate-binding cassette subfamily B member 1 (ABCB1) mRNA expression in patients with de novo chronic myelogenous leukemia : the role of different cell types

[rok vydání 2011, impact factor 2.580]

[33]

Cernan, M.; Szotkowski, T.; Hisemova, M.; Cetkovsky, P.; et al.

Blastic plasmacytoid dendritic cell neoplasm: first retrospective study in the Czech Republic

[rok vydání 2020, impact factor 2.575 ]

[34]

Marková, J.; Michková, P.; Burčková, K.; Březinová, J.; Michalová, K.; Dohnalová, A.; Soukupová Maaloufová, J.; Soukup, P.; Vítek, A.; Cetkovský, P.; Schwarz, J.

Prognostic impact of DNMT3A mutations in patients with intermediate cytogenetic risk profile acute myeloid leukemia

[rok vydání 2011, impact factor 2.548 ]

[35]

Salaj, P.; Brabec, P.; Penka, M.; Pohlreichova, V.; Smejkal, P.; Cetkovsky, P.; Dusek, L.; Hedner, U.

Effect of rFVIIa dose and time to treatment on patients with haemophilia and inhibitors : analysis of HemoRec registry data from the Czech Republic

[rok vydání 2009, impact factor 2.505]

[36]

Salaj, P.; Gurlich, R.; Svorcova, V.; Markova, M.; Cetkovsky, P.

Prophylactic preparation and surgical extirpation of a very large abdominal blood cyst in a severe haemophilia A patient with inhibitors managed by rFVIIa

[rok vydání 2008, impact factor 2.505]

[37]

Marková, M.; Brodská, H.; Malíčková, K.; Válková, V.; Cetkovský, P.; Kolář, M.; Haluzík, M.

Substantially elevated C-reactive protein (CRP), together with low levels of procalcitonin (PCT), contributes to diagnosis of fungal infection in immunocompromised patients

[rok vydání 2014, impact factor 2.495 ]

[38]

Válková, V.; Schwarz, J.; Vítek, A.; Marková, M.; Pohlreich, D.; Benešová, K.; Michalová, K.; Cetkovský, P.; Trněný, M.

The effect of allogeneic stem cell transplantation on high risk chronic lymphocytic leukaemia: a single centre retrospective analysis

[rok vydání 2010, impact factor 2.475]

[39]

Salaj, P.; Kubes, R.; Cetkovsky, P.; Capova, I.; Penka, M.; Ovesna, P.; Mesterton, J.; Lindgren, P.

Economic evaluation of rFVIIa high initial dose compared to rFVIIa standard initial dose in patients with haemophilia with inhibitors using the Czech HemoRec registry

[rok vydání 2013, impact factor 2.447 ]

[40]

Marinov, I.; Kohoutová, M.; Tkáčová, V.; Pešek, A.; Čermák, J.; Cetkovský, P.

Clinical relevance of CD157 for rapid and cost-effective simultaneous evaluation of PNH granulocytes and monocytes by flow cytometry

[rok vydání 2014, impact factor 2.401 ]